63
Participants
Start Date
April 3, 2019
Primary Completion Date
March 10, 2023
Study Completion Date
March 10, 2023
Lidocaine 4% Topical Application Cream [LMX 4]
Run-in Step: All subjects receive 32 mg (4 cm ribbon of cream) applied, bilaterally, over greater occipital nerve.
Lidocaine Hydrochloride 2 mg/mL Injectable Solution
Subjects, who continue to experience headache pain after the run-in step, receive 2 (2 mL) injections of the active treatment.
Normal Saline
Subjects, who continue to experience headache pain after the run-in step, receive 2 (2 mL) injections of the comparator.
Children's Hospital of Philadelphia, Philadelphia
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Children's Hospital of Philadelphia
OTHER